Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Sep 21 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 3 pages · English

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 21, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases